Seitz, Michael

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2016

Villiger, Peter M; Adler, Sabine; Kuchen, Stefan; Wermelinger, Felix; Dan, Diana; Fiege, Veronika; Bütikofer, Lukas; Seitz, Michael; Reichenbach, Stephan (2016). Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet, 387(10031), pp. 1921-1927. Elsevier 10.1016/S0140-6736(16)00560-2

Aeberli, Daniel; Kamgang, Richard; Balani, Deepak; Hofstetter, Wilhelm; Villiger, Peter; Seitz, Michael (2016). Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis. RMD open, 2(1), e000079. BMJ Publishing Group 10.1136/rmdopen-2015-000079

2015

Seitz, Michael (2015). [Polymyalgia rheumatica: What is the current status?]. Zeitschrift für Rheumatologie, 74(6), pp. 507-510. Springer 10.1007/s00393-014-1548-z

Traunecker, Emmanuel; Gardner, Rui; Fonseca, João Eurico; Polido-Pereira, Joaquim; Seitz, Michael; Villiger, Peter; Iezzi, Giandomenica; Padovan, Elisabetta (2015). Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytes. European journal of immunology, 45(5), pp. 1414-1425. Wiley-VCH 10.1002/eji.201445100

2014

van Laar, Jacob M; Farge, Dominique; Sont, Jacob K; Naraghi, Kamran; Marjanovic, Zora; Larghero, Jérôme; Schuerwegh, Annemie J; Marijt, Erik W A; Vonk, Madelon C; Schattenberg, Anton V; Matucci-Cerinic, Marco; Voskuyl, Alexandre E; van de Loosdrecht, Arjan A; Daikeler, Thomas; Kötter, Ina; Schmalzing, Marc; Martin, Thierry; Lioure, Bruno; Weiner, Stefan M; Kreuter, Alexander; ... (2014). Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA : the journal of the American Medical Association, 311(24), pp. 2490-2498. American Medical Association 10.1001/jama.2014.6368

2013

Seitz, Michael (2013). Arthritisabklärung. Rheuma Schweiz, 5(4), pp. 11-17. Rheuma Schweiz

Seitz, Michael; Gerber, Markus (2013). Grossgefässvaskulitiden-«Update». Diagnostik und Therapie 2012. Swiss Medical Forum, 13(10), pp. 201-205. EMH Swiss Medical Publishers

2012

Balani, Deepak; Aeberli, Daniel; Hofstetter, Willy; Seitz, Michael (2012). Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. Arthritis & rheumatism, 65(2), pp. 236-246. Hoboken, N.J.: Wiley-Blackwell 10.1002/art.37762

Seitz, Mn (2012). Reply to the letter to the editor of francisco José Fernández-Fernández et al. Swiss medical weekly, 142, w13504. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13528

Seitz, M (2012). Reply to the letter to the editor "Might tocilizumab be useful in patients with giant-cell arteritis and normal ESR ?". Swiss medical weekly(142) Muttenz: EMH Schweizerischer Ärzteverlag

Seitz, M (2012). Rituximab bei ANCA-assoziierten Vaskulitiden. Rheuma Schweiz(5), pp. 7-10. Zürich: Rheuma Schweiz

2011

Seitz, Michael; Reichenbach, Stephan; Bonel, Harald M; Adler, Sabine; Wermelinger, Felix; Villiger, Peter M (2011). Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss medical weekly, 141, w13156. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13156

Aeberli, Daniel; Schett, Georg; Eser, Prisca; Seitz, Michael; Villiger, Peter M (2011). Serum Dkk-1 levels of DISH patients are not different from healthy controls. Joint bone spine, 78(4), pp. 422-3. Paris: Elsevier Masson SAS 10.1016/j.jbspin.2011.02.015

2010

Seitz, M; Reichenbach, S; Möller, B; Zwahlen, M; Villiger, PM; Dufour, Jean-François (2010). Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Annals of the rheumatic diseases, 69(6), pp. 1148-1150. London: BMJ Publishing Group 10.1136/ard.2009.116194

Eser, Prisca; Bonel, Harald; Seitz, Michael; Villiger, Peter M; Aeberli, Daniel (2010). Patients with diffuse idiopathic skeletal hyperostosis do not have increased peripheral bone mineral density and geometry. Rheumatology, 49(5), pp. 977-81. Oxford: Oxford University Press 10.1093/rheumatology/keq014

Hausmann, Oliver V; Seitz, Michael; Villiger, Peter M; Pichler, Werner J (2010). The complex clinical picture of side effects to biologicals. Medical clinics of North America, 94(4), 791-804, xi-ii. Philadelphia, Pa.: Elsevier 10.1016/j.mcna.2010.03.001

Seitz, Michael (2010). [Which clinical symptoms suggest distinct autoantibody measurements?]. Praxis - schweizerische Rundschau für Medizin, 99(23), pp. 1429-34. Bern: Huber

2009

Evison, John; Farese, Stefan; Seitz, Michael; Uehlinger, Dominik E; Furrer, Hansjakob; Mühlemann, Kathrin (2009). Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clinical infectious diseases, 48(10), pp. 1402-12. Cary, N.C.: Oxford University Press 10.1086/598193

2008

Gengenbacher, M; Sebald, H-J; Villiger, P M; Hofstetter, W; Seitz, M (2008). Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Annals of the rheumatic diseases, 67(5), pp. 620-4. London: BMJ Publishing Group 10.1136/ard.2007.076711

seitz, m (2008). Sjögrens-Syndrom. Therapeutische Umschau(65), pp. 279-82. Bern: Huber

2007

Seitz, M; Wirthmüller, U; Möller, B; Villiger, P M (2007). The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology, 46(1), pp. 93-6. Oxford: Oxford University Press 10.1093/rheumatology/kel175

Provide Feedback